Applied Therapeutics
(NASDAQ:APLT)
$6.865
0.015[0.22%]
Last update: 12:26PM Get Real Time Here
Consensus Rating1
Outperform
Highest Price Target1
$14.00
Lowest Price Target1
$2.25
Consensus Price Target1
$10.04

Applied Therapeutics Stock (NASDAQ:APLT), Analyst Ratings, Price Targets, Predictions

Applied Therapeutics Inc has a consensus price target of $10.04, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from RBC Capital, UBS, and UBS on March 26, 2024, March 15, 2024, and March 6, 2024. With an average price target of $12.33 between RBC Capital, UBS, and UBS, there's an implied 79.66% upside for Applied Therapeutics Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Feb
2
Mar
3
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
UBS
Leerink Partners
Citigroup
Baird

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Applied Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/26/2024APLTBuy Now
Applied Therapeutics
$6.8774.8%RBC Capital
Brian Abrahams
→ $12Initiates → OutperformGet Alert
03/15/2024APLTBuy Now
Applied Therapeutics
$6.8789.37%UBS
Esther Rajavelu
$12 → $13MaintainsBuyGet Alert
03/06/2024APLTBuy Now
Applied Therapeutics
$6.8774.8%UBS
Esther Rajavelu
$4 → $12MaintainsBuyGet Alert
02/22/2024APLTBuy Now
Applied Therapeutics
$6.8774.8%Leerink Partners
Joseph Schwartz
→ $12Initiates → OutperformGet Alert
02/16/2024APLTBuy Now
Applied Therapeutics
$6.871.97%Citigroup
Yigal Nochomovitz
$5 → $7MaintainsBuyGet Alert
04/25/2023APLTBuy Now
Applied Therapeutics
$6.87103.93%Baird
Brian Skorney
$18 → $14MaintainsOutperformGet Alert
04/05/2023APLTBuy Now
Applied Therapeutics
$6.87-27.17%Citigroup
Yigal Nochomovitz
$23 → $5MaintainsBuyGet Alert
08/17/2022APLTBuy Now
Applied Therapeutics
$6.87235.03%Citigroup
Yigal Nochomovitz
$29 → $23MaintainsBuyGet Alert
08/16/2022APLTBuy Now
Applied Therapeutics
$6.87-67.23%Barclays
Carter Gould
$2.5 → $2.25MaintainsEqual-WeightGet Alert
05/20/2022APLTBuy Now
Applied Therapeutics
$6.87322.43%Citigroup
Yigal Nochomovitz
$30 → $29MaintainsBuyGet Alert
03/21/2022APLTBuy Now
Applied Therapeutics
$6.87-63.58%Barclays
Carter Gould
$7 → $2.5MaintainsEqual-WeightGet Alert
01/04/2022APLTBuy Now
Applied Therapeutics
$6.871.97%Barclays
Carter Gould
$44 → $7DowngradeOverweight → Equal-WeightGet Alert
08/27/2021APLTBuy Now
Applied Therapeutics
$6.8745.67%Goldman Sachs
Madhu Kumar
DowngradeNeutral → SellGet Alert

FAQ

Q

What is the target price for Applied Therapeutics (APLT)?

A

The latest price target for Applied Therapeutics (NASDAQ: APLT) was reported by RBC Capital on March 26, 2024. The analyst firm set a price target for $12.00 expecting APLT to rise to within 12 months (a possible 74.80% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Applied Therapeutics (APLT)?

A

The latest analyst rating for Applied Therapeutics (NASDAQ: APLT) was provided by RBC Capital, and Applied Therapeutics initiated their outperform rating.

Q

When was the last upgrade for Applied Therapeutics (APLT)?

A

There is no last upgrade for Applied Therapeutics.

Q

When was the last downgrade for Applied Therapeutics (APLT)?

A

The last downgrade for Applied Therapeutics Inc happened on January 4, 2022 when Barclays changed their price target from $44 to $7 for Applied Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Applied Therapeutics (APLT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Applied Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Applied Therapeutics was filed on March 26, 2024 so you should expect the next rating to be made available sometime around March 26, 2025.

Q

Is the Analyst Rating Applied Therapeutics (APLT) correct?

A

While ratings are subjective and will change, the latest Applied Therapeutics (APLT) rating was a initiated with a price target of $0.00 to $12.00. The current price Applied Therapeutics (APLT) is trading at is $6.87, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch